Diet and exercise in cystic fibrosis /
Diet and Exercise in Cystic Fibrosis, a unique reference edited by distinguished and internationally recognized nutritionist and immunologist Ronald Ross Watson, fills the gap in the current dietary modalities aimed at controlling cystic fibrosis. Using expert evaluation on the latest studies of the...
Clasificación: | Libro Electrónico |
---|---|
Otros Autores: | |
Formato: | Electrónico eBook |
Idioma: | Inglés |
Publicado: |
London :
Academic Press,
�2015.
|
Temas: | |
Acceso en línea: | Texto completo |
Tabla de Contenidos:
- Front Cover; DIET AND EXERCISE IN CYSTIC FIBROSIS; Copyright; Dedication; Contents; Preface; Acknowledgments; Biography; List of Contributors; SECTION A -OVERVIEW OF NUTRITION AND DIETS IN CYSTIC FIBROSIS; 1 -Nutrition for Pregnant Women Who Have Cystic Fibrosis; 1.1 INTRODUCTION; 1.2 HISTORICAL PERSPECTIVE; 1.3 NUTRITION: REVIEW OF THE LITERATURE; 1.4 CLINICAL GUIDANCE; 1.5 CONCLUSION; References; 2
- Disordered Eating and Body Image in Cystic Fibrosis; 2.1 INTRODUCTION; 2.2 QUALITY OF LIFE; 2.3 BODY IMAGE; 2.4 EATING BEHAVIORS.
- 2.5 BODY DISSATISFACTION AND DISORDERED EATING: IDENTIFICATION, TREATMENT, AND INTERVENTION STRATEGIES2.6 CONCLUSION; References; 3- Neonatal Screening and Nutrition/Growth in Cystic Fibrosis: A Review; 3.1 INTRODUCTION; 3.2 REVIEW OF THE LITERATURE; 3.3 RCTS STUDIES; 3.4 STUDIES USING CF REGISTRY DATA; 3.5 COHORT OBSERVATIONAL STUDIES; 3.6 DISCUSSION; References; 4
- Cystic Fibrosis Nutrition: Outcomes, Treatment Guidelines, and Risk Classification; 4.1 NUTRITION AND OUTCOMES; 4.2 ASSESSING WEIGHT CHANGE AND GROWTH IN CF; 4.3 ENERGY GUIDELINES; 4.4 VITAMINS AND MINERALS; 4.5 MALABSORPTION.
- 4.6 INCREASING INTAKE4.7 COMORBID DISEASES/COMPLICATIONS THAT AFFECT NUTRITION; 4.8 NUTRITION SCREENING AND RISK CLASSIFICATION IN A CLINICAL SETTING; References; 5
- Clinic, Nutrition, and Spirometry in Cystic Fibrosis; 5.1 INTRODUCTION; 5.2 CLINICAL CHARACTERISTICS; 5.3 METHODS OF ASSESSING GROWTH AND PULMONARY FUNCTION; 5.4 FACTORS THAT INTERFERE WITH THE GROWTH OF CF PATIENTS; 5.5 METABOLIC PROCESS IN CYSTIC FIBROSIS: HIGH CALORIE CONSUMPTION; 5.6 METABOLIC AND NUTRITIONAL SECONDARY PROCESSES; 5.7 RELATIONSHIP BETWEEN ENDOCRINE-METABOLIC DISEASES AND LUNG DEVELOPMENT.
- 5.8 NUTRITION AND LUNG FUNCTION5.9 CONCLUSION; References; 6
- Family Mealtimes and Children with Cystic Fibrosis; CONCLUSION AND FUTURE DIRECTIONS; References; 7
- Disturbed Sleep Behaviors and Melatonin in Sleep Dysfunction and Treatment of Cystic Fibrosis; 7.1 INTRODUCTION; 7.2 SLEEP DYSFUNCTION IN CYSTIC FIBROSIS; 7.3 MELATONIN AND CF; 7.4 CONCLUSION; References; 8
- Age at Diagnosis and Disease Progression of Cystic Fibrosis; 8.1 AGE AT DIAGNOSIS OF CF; 8.2 MORBIDITY AT DIAGNOSIS AND INTRODUCTION TO MORBIDITY; 8.3 NUTRITIONAL MORBIDITY; 8.4 LUNG MORBIDITY; 8.5 LIVER MORBIDITY.
- 8.6 OVERALL MORBIDITY8.7 DISCUSSION; Acknowledgments; References; 9
- The Effects of Caffeine, Alcohol, and Tobacco in Cystic Fibrosis; KEY POINTS; 9.1 INTRODUCTION; 9.2 CYSTIC FIBROSIS OVERVIEW; 9.3 CAFFEINE AND PATIENTS WITH CF; 9.4 ALCOHOL AND PATIENTS WITH CF; 9.5 TOBACCO AND PATIENTS WITH CF; 9.6 SUMMARY; References; 10
- Eating Disorders and Disturbed Eating Attitudes and Behaviors Typical in CF; 10.1 POOR NUTRITIONAL STATUS IN CF; 10.2 EVIDENCE OF EDS IN CF; 10.3 DISTURBED EATING ATTITUDES AND BEHAVIORS IN CF; 10.4 MEASURES OF DEABS FOR THE CF POPULATION; 10.5 CONCLUSION; References.